Pediatric Second Influenza Dose Portal Reminder Recall

Completed · Not applicable

Conditions studied: Influenza, Respiratory Tract Infections

In brief

This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System. The study design is a parallel 2-arm trial. The parallel arms are 1) a reminder letter for the second dose of influenza vaccine (reminder messages sent via the patient portal) with a direct appointment scheduling link included in the reminder and 2) a reminder letter for the second dose of influenza vaccine, but no direct appointment scheduling link included.

Key facts

Study ID

NCT04668417

Run by

University of California, Los Angeles

People needed

698

Starts

2020-12-15

Expected to finish

2021-04-01

Last updated by the study team

2021-05-28

Who can join

Age: 1 and older, up to 3. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient within the UCLA Health System identified as a primary care patient per an internal algorithm
• Identified as being overdue for a second dose of influenza vaccine.

You may not qualify if…

• Patient within the UCLA Health System not identified as a primary care patient per an internal algorithm
• Not due for a second dose of influenza vaccine.

Where it is running

• University of California LA — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.